Salvia’s neurostimulatory foils raise 26 million
Salvia Bioelectronics has raised 26 million euros to develop neurostimulation therapy for chronic migraine sufferers.
Salvia Bioelectronics has raised 26 million euros to develop neurostimulation therapy for chronic migraine sufferers.
De Eindhovense startup Salvia Bioelectronics heeft 1,3 miljoen startkapitaal opgehaald.